Tuesday, February 06, 2018 10:26:21 PM
Once you have been trading for awhile you will see many stocks get shot out of the sky for all kinds of reasons. I like to trade small cap Biotech stocks so it is fairly normal for me to see swings in either direction in a matter of minutes.
I learned from the school of real hard knocks that the most difficult thing to do after buying a stock is when to sell. I cannot time the tops or bottoms so once I buy a stock I go ahead and set my GTC sell order that will give me a reasonable profit for a portion of my shares. Very rarely do I get all profit possible out of a trade, but I would rather have a nice profit than try and time a top and miss an exit point. I then ride the stock as long as I can selling the rest of my shares along the way. If a stock turns on me, I reevaluate my position and why I bought in the first place. If nothing has changed, I continue with the trade. Otherwise, I take my loss, lick my wounds and find another stock to trade.
I think that you place too much emphasis on Sessions. First, in the long run his opinion will not affect the MJ trend now occurring IMO. Second, if you read between the lines he said it will be up to the states to decide how to address the issue. I do not foresee CA turning back the tide.
Last, IMO this stock will act like a Biotech stock in that it will be very volatile at times. As you have seen, any hint of bad news will knock it down, but just as well, any hint of really good news may send it up quickly. Right now is probably the time to set your first exit point and let your computer do all the work. That way you take all the emotion out of your investment.
Recent GBLX News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 08/30/2024 09:13:41 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 09:24:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 07:12:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2024 09:39:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 10:07:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/10/2023 02:00:29 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM